Skip to main content
Research Vendor

LiveWell Peptides

Online VendorUnited Stateslivewellpeptides.com ↗
  • 12 compounds tested
COAs on file
12

across 2 labs

Independently confirmed
0

none on record

Median purity
99.61%

▼ 0.05 vs corpus

At or above market
6/12

compounds comparable

Most recent
8 Jan

9 months ago

livewellpeptides.com · registry record not yet fetched · first indexed by us 28 Jun 2026 · listing active

Research use only. This vendor supplies peptides for laboratory and research purposes — not for human consumption or therapeutic use. PeptideBase does not endorse or guarantee product quality. Verify third-party lab testing before any research use.

Vendor's own wordPublishes 3 of 6 disclosure signals — 1 document-backed, 2 vendor-stated · checked 6 Jul 2026

Vendor-supplied · Not verified by PeptideBase

What this vendor publishes about itself, repeated here. Disclosure is not verification; only independent lab results change that.

12 certificates on file, all self-published by the vendor. Median purity 99.61%, against 99.66% across all 1,295 certificates we score. Six of twelve compounds test at or above their market median. The exception is a Retatrutide lot at 98.76% — 0.98 points below the 99.74% median for that compound, and the only result here outside the corpus's middle 80%.

Where this evidence comes from

Evidence provenance

12 self-published
COAs the vendor posted on their own site.

Recorded for completeness. A self-published document doesn't count as confirmed on its own — the document is real, the chain of custody isn't independent.

Purity vs market

Every certificate, placed against the median for its own compound across all 1,295 results we score.

7 of 12 results sit within ±0.4 points of their market median.

Lab-sourcedSelf-published
±0.4Market median−1.0−0.5+0.5+1.0Retatrutide 98.76%

Lab testing record

Every COA we hold for LiveWell Peptides.

How these certificates can be checked

Of the 12 certificates we hold for LiveWell Peptides:

  • 2No lookup reference on the report
  • 10Lab publishes no lookup

These do not all sit in the same state, so no single statement covers them. Each certificate below says which applies to it.

PanelSourceReference
AOD-9604MZ Biolabs8 Jan 2699.96%+0.30—Self-publishedView COA ↗
MZ Biolabs does not publish a way to look up reports.
RetatrutideMZ Biolabs4 Jan 2698.76%−0.98—Self-publishedView COA ↗
MZ Biolabs does not publish a way to look up reports.
TirzepatideMZ Biolabs3 Jan 2699.93%+0.12—Self-publishedView COA ↗
MZ Biolabs does not publish a way to look up reports.
NAD+MZ Biolabs3 Jan 2699.43%−0.14—Self-publishedView COA ↗
MZ Biolabs does not publish a way to look up reports.
IGF-1 LR3MZ Biolabs3 Jan 2698.93%±0.00(n=11)—Self-publishedView COA ↗
MZ Biolabs does not publish a way to look up reports.
GHK-CuMZ Biolabs9 Dec 2599.93%+0.17—Self-publishedView COA ↗
MZ Biolabs does not publish a way to look up reports.
BPC-157MZ Biolabs3 Dec 2599.93%+0.37—Self-publishedView COA ↗
MZ Biolabs does not publish a way to look up reports.
GlutathioneMZ Biolabs3 Nov 2599.13%−0.42—Self-publishedView COA ↗
MZ Biolabs does not publish a way to look up reports.
IpamorelinMZ Biolabs3 Nov 2599.03%−0.75—Self-publishedView COA ↗
MZ Biolabs does not publish a way to look up reports.
SelankMZ Biolabs30 Oct 2599.03%−0.68—Self-publishedView COA ↗
MZ Biolabs does not publish a way to look up reports.
PT-141Janoshik Analytical4 Sept 2599.78%−0.10—Self-publishedView COA ↗
Janoshik Analytical publishes a report lookup. This certificate does not carry a reference we can use with it.
TesamorelinJanoshik Analytical14 Jul 2599.89%+0.45—Self-publishedView COA ↗
Janoshik Analytical publishes a report lookup. This certificate does not carry a reference we can use with it.
12 certificates

The labs behind these results

MZ Biolabs
Self-published
Results
10
Median
99.28%
Window
Oct 2025–Jan 2026
Janoshik Analytical
Self-published
Results
2
Median
99.84%
Window
Jul–Sep
All recognised labs →1,336 certificates scored · 71 vendors

In the vendor's own words

Written by the vendor · Not verified by PeptideBase

LiveWell Peptides is a domestic supplier of research-grade peptides, ensuring 99% purity for laboratory use. They operate a cGMP-certified facility in Dallas, Texas, providing high-quality compounds along with rigorous testing and documentation for researchers.

#Testing disclosure

Publishes COAsVendor-stated
Yes
COA accessVendor-stated
Published on the vendor’s website
Named lab(s)Vendor-stated
MZ Biolabs
Last observedOur record
6 Jul 2026
Batch numbers shownOur record
Yes

Research pricing

Lowest tracked SKU per compound. $/mg is the comparable figure; the range spans the middle 50% of vendors.
Tracked prices15 of 22 compounds
CompoundPriceSize$/mgvs tracked rangeSKUs
5-Amino-1MQ$89.9950 mg$1.80
$1.50$5.83
2
AOD-9604$185.0010 mg$18.50
$7.77$14.03
2
BPC-157$85.9910 mg$8.60
$4.25$6.99
2
Dihexa$129.9910 mg$13.00no market range1
DSIP$42.0010 mg$4.20
$4.45$8.00
3
Epithalon$160.0050 mg$3.20
$2.22$4.06
1
GHK-Cu$125.00100 mg$1.25
$0.55$0.99
1
Melanotan II$50.0010 mg$5.00
$3.01$4.80
1
PT-141$75.0010 mg$7.50
$2.93$5.00
1
Selank$99.0010 mg$9.90
$3.95$5.51
2
Semaglutide$190.0010 mg$19.00
$5.76$14.45
2
Semax$59.9910 mg$6.00
$3.22$5.95
2
Sermorelin$75.0010 mg$7.50
$6.92$10.57
1
SS-31$200.0050 mg$4.00
$3.65$7.00
2
Tesamorelin$100.005 mg$20.00
$6.32$10.57
1
Prices may vary by quantity — verify directly with the vendor.Report a pricing error

Research catalog

22 compounds listed. Linked entries have a research summary in the library.
15 priced · 7 listed without a tracked priceCompare all 22 across vendors →
PeptideBase badge

Add this badge to your website

Profile last updated

Cite this page

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). LiveWell Peptides — Research Vendor Profile. Retrieved October 26, 2026, from https://peptidebase.io/research-vendors/livewell-peptides

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.